Anti-PCSK2 antibody (1-220) (STJ111361)

SKU:
STJ111361

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-PCSK2 (1-220) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:1000-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: PCSK2
Gene ID: 5126
Uniprot ID: NEC2_HUMAN
Immunogen Region: 1-220
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-220 of human PCSK2 (NP_002585.2).
Immunogen Sequence: MKGGCVSQWKAAAGFLFCVM VFASAERPVFTNHFLVELHK GGEDKARQVAAEHGFGVRKL PFAEGLYHFYHNGLAKAKRR RSLHHKQQLERDPRVKMALQ QEGFDRKKRGYRDINEIDIN MNDPLFTKQWYLINTGQADG TPGLDLNVAEAWELGYTGKG VTIGIMDDGIDYLHPDLASN YNAEASYDFSSNDPYPYPRY TDDWFNSHGTRCAGEVSAAA
Function Serine endopeptidase which is involved in the processing of hormone and other protein precursors at sites comprised of pairs of basic amino acid residues. Responsible for the release of glucagon from proglucagon in pancreatic A cells.
Protein Name Neuroendocrine Convertase 2
Nec 2
Kex2-Like Endoprotease 2
Prohormone Convertase 2
Proprotein Convertase 2
Pc2
Database Links Reactome: R-HSA-264876
Cellular Localisation Cytoplasmic Vesicle
Secretory Vesicle
Secreted
Localized In The Secretion Granules
Alternative Antibody Names Anti-Neuroendocrine Convertase 2 antibody
Anti-Nec 2 antibody
Anti-Kex2-Like Endoprotease 2 antibody
Anti-Prohormone Convertase 2 antibody
Anti-Proprotein Convertase 2 antibody
Anti-Pc2 antibody
Anti-PCSK2 antibody
Anti-NEC2 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance